UDI: Value Beyond Compliance
In this AHRMM webcast, Karen Conway, executive director of industry relations and value at GHX discusses her research with the FDA on the value of UDI adoption in health care organizations.
AHRMM’s Mike Schiller, senior director of supply chain, joins the conversation by describing the actions AHRMM is taking with the Learning UDI Community (LUC) to identify adoption practices and move beyond compliance.
Related Resources
Letter/Comment
An announcement of the Final Rule issued by the IRS.
Advisory
The Food and Drug Administration (FDA) UDI system is being phased in over several years.
Toolkits/Methodology
How-to guide to managing IV disruptions.
Magazine & Journal Articles
AHRMM's Cost, Quality, and Outcomes (CQO) Movement will provide training and education to help supply chain professionals make the correlation…
Letter/Comment
Recent Guidance on Meaningful Use of EHRs Makes Compliance More Difficult.